Wednesday, 24 September 2025

Regulatory

UK Seizes Strategic Opportunity in India Through Trade Deal Tied to Atmanirbhar Bharat

A landmark trade pact strengthens Britain’s foothold in India’s booming self-reliant economy, creating new export, investment, and manufacturing opportunities for UK enterprises....

Opus Genetics and Global RDH12 Alliance Unite to Accelerate Gene Therapy for Childhood Blindness

Collaboration aims to advance RDH12-focused treatments for inherited retinal diseases, offering hope to children affected by vision loss worldwide...

Roche Secures CE Mark for Alzheimer’s Blood Test

New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe....

Philips Secures FDA Clearance for Image-Guided Navigation Technology in Prostate Cancer Care

Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment...

The FDA Is Phasing Out Animal Testing

As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....

Rebuilding the Drug Repurposing Pipeline with Better Data

How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...

Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough

Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....

Canada Grants Patent to bioAffinity Technologies for CyPath® Lung Diagnostic Test

New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...

Autonomix Medical Secures New U.S. Patent for Advancing Nerve-Targeted, Minimally Invasive Therapies

Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions ...

Takeda Secures FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices

New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy...